Chi-yun C. Kung, Ph.D.
Affiliations: | 2005 | University of California, San Francisco, San Francisco, CA |
Area:
signal transduction pathways in cells and whole organismsGoogle:
"Chi-yun Kung"Mean distance: 8.45 | S | N | B | C | P |
Parents
Sign in to add mentorKevan Michael Shokat | grad student | 1999-2004 | UCSF | |
(Chemical genomic profiling to identify intracellular targets of protein kinase inhibitors.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Grace RF, Rose C, Layton DM, et al. (2019) Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency. The New England Journal of Medicine. 381: 933-944 |
Garate Z, Quintana-Bustamante O, Crane AM, et al. (2015) Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells. Stem Cell Reports |
Chang CC, Naik MT, Huang YS, et al. (2011) Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation. Molecular Cell. 42: 62-74 |
Blair JA, Rauh D, Kung C, et al. (2007) Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nature Chemical Biology. 3: 229-38 |
Liu Y, Kung C, Fishburn J, et al. (2004) Two cyclin-dependent kinases promote RNA polymerase II transcription and formation of the scaffold complex. Molecular and Cellular Biology. 24: 1721-35 |
Bishop AC, Shah K, Liu Y, et al. (1998) Design of allele-specific inhibitors to probe protein kinase signaling. Current Biology : Cb. 8: 257-66 |